Literature DB >> 6604159

Sialographic study in patients with and without antibodies to Sjögren's syndrome A (Ro).

K Miyachi, M Naito, Y Maeno, S Suzuki, T Hamamoto, M Sugiura, M Kasahara, K Torikai, H Umeda.   

Abstract

Antibodies to Sjögren's syndrome A (SS-A) (Ro) antigen were detected in 13 of 16 (81%) patients with sicca alone and 18 of 34 (54%) patients with systemic lupus erythematosus (SLE). Antibodies to Sjögren's syndrome B (SS-B) (La, Ha) antigen were detected in 7 of 16 (44%) patients with sicca alone. These percentages were statistically higher than those in other types of connective tissue diseases. There were no direct correlations between titers of antibodies to SS-A (Ro) and severity of sialographic abnormalities in 35 patients with Sjögren's syndrome (SS). However comparison of a total of 20 sialograms obtained from patients with antibodies to SS-A (Ro) showed more advanced changes than in a total of 36 sialograms from patients without antibodies to SS-A (Ro) in systemic lupus erythematosus, mixed connective tissue disease, progressive systemic sclerosis and rheumatoid arthritis. These results suggested that antibody to SS-A (Ro) may be a good indicator of subclinical SS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604159

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Follow up study of labial salivary gland lesions in primary Sjögren's syndrome.

Authors:  J P Leroy; Y L Pennec; C Soulier; J M Berthelot; G Letoux; P Youinou
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  The clinical significance of the detection of anti-Ro/SS-A and anti-La/SS-B autoantibodies using purified recombinant proteins in primary Sjögren's syndrome.

Authors:  H M Markusse; C H Veldhoven; A J Swaak; R T Smeenk
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

3.  The diagnosis value of beta 2-microglobulin and immunoglobulins in primary Sjögren's syndrome.

Authors:  S Maddali Bongi; G Campana; A D'Agata; C Palermo; G Bianucci
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.